Depomed Announces Appointment of Louis J. Lavigne, Jr. to Board of Directors
July 08, 2013 at 16:31 PM EDT
Depomed, Inc. (NASDAQ: DEPO ) today announced the appointment of Louis J. Lavigne, Jr. to the company's Board of Directors, and to the Board's Audit Committee. Mr. Lavigne is the former Executive Vice President and Chief Financial Officer of Genentech. "Lou is a highly skilled life sciences veteran
